Chemical Structure (Krazati 01)
Krazati Tablet, Coated
Product Images NDC 80739-812
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Krazati (NDC 80739-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mirati Therapeutics, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (180 Tablet Bottle Carton)
This appears to be a description of a medication called Adagrasib. The text contains information related to its dosage and administration. It also mentions the manufacturer and prescription details of the tablet. The medication is for oral use and should be stored at a temperature range of 20°C to 25°C. The text also mentions that it's important to keep the medication away from children. The brand name of this medication appears to be MIRATI THERAPEETICS.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
